Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies
- PMID: 18821675
- PMCID: PMC2682358
- DOI: 10.1002/art.23899
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies
Abstract
Objective: To investigate possible associations of GM and KM markers with adult and juvenile forms of the idiopathic inflammatory myopathies (IIMs) in Caucasian and African American patients.
Methods: We performed serologic analyses of polymorphic determinants associated with immunoglobulin gamma heavy chains (GM) and kappa light chains (KM) in large populations of Caucasian patients (n= 514 [297 adults and 217 children]) and African American patients (n=123 [73 adults and 50 children]) with IIM representing the major clinical and autoantibody groups.
Results: For Caucasian patients with dermatomyositis (DM), the Gm 3 23 5,13 phenotype was a risk factor in both adults (odds ratio [OR] 2.2, corrected P [Pcorr]=0.020) and children (OR 2.2, Pcorr=0.0013). Of interest, the GM 13 allotype was a risk factor for juvenile DM in both Caucasian subjects (OR 3.9, Pcorr<0.0001) and African American subjects (OR 4.8, Pcorr=0.033). However, the Gm 1,3,17 5,13,21 phenotype was a risk factor for juvenile DM in Caucasian subjects but not African American subjects. Among the IIM autoantibody groups, Gm 3 23 5,13 was a risk factor in Caucasian adults with anti-Jo-1 autoantibodies (OR 3.4, Pcorr=0.0031), while the GM 3 allotype was protective in adults with anti-threonyl-transfer RNA synthetase or anti-U RNP autoantibodies (OR 0.1, Pcorr=0.047 and OR 0.2, Pcorr=0.034, respectively). In contrast, GM 6 was a risk factor in African American adults with anti-signal recognition particle autoantibodies (OR 7.5, Pcorr=0.041).
Conclusion: These data suggest that polymorphic alleles of GM and KM loci are differentially associated with IIM subgroups defined by age, ethnicity, clinical features, and autoantibody status, and expand the list of immune response genes that are possibly important in the pathogenesis of myositis.
Similar articles
-
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.Medicine (Baltimore). 2006 Mar;85(2):111-127. doi: 10.1097/01.md.0000217525.82287.eb. Medicine (Baltimore). 2006. PMID: 16609350
-
Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.Arthritis Rheum. 2002 Jul;46(7):1885-93. doi: 10.1002/art.10358. Arthritis Rheum. 2002. PMID: 12124873
-
Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci.Arthritis Rheum. 1999 Jun;42(6):1285-90. doi: 10.1002/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1. Arthritis Rheum. 1999. PMID: 10366124
-
An update on the immunogenetics of idiopathic inflammatory myopathies: major histocompatibility complex and beyond.Curr Opin Rheumatol. 2009 Nov;21(6):588-93. doi: 10.1097/BOR.0b013e3283315a22. Curr Opin Rheumatol. 2009. PMID: 19730377 Review.
-
Immunogenetics of inflammatory myopathies.Baillieres Clin Neurol. 1993 Nov;2(3):579-97. Baillieres Clin Neurol. 1993. PMID: 8156144 Review.
Cited by
-
Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes.J Proteome Res. 2011 Jul 1;10(7):2969-78. doi: 10.1021/pr200397h. Epub 2011 Jun 8. J Proteome Res. 2011. PMID: 21609021 Free PMC article.
-
Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.Curr Rheumatol Rev. 2010 May;6(2):108-119. doi: 10.2174/157339710791330740. Curr Rheumatol Rev. 2010. PMID: 21941374 Free PMC article.
-
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.Nat Rev Neurol. 2011 Jun 8;7(6):343-54. doi: 10.1038/nrneurol.2011.63. Nat Rev Neurol. 2011. PMID: 21654717 Review.
-
Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.Arthritis Res Ther. 2013 Apr 4;15(2):R48. doi: 10.1186/ar4207. Arthritis Res Ther. 2013. PMID: 23557279 Free PMC article.
-
Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han.Immunol Res. 2016 Feb;64(1):204-12. doi: 10.1007/s12026-015-8738-x. Immunol Res. 2016. PMID: 26603167
References
-
- Miller FW. Inflammatory Myopathies: Polymyositis, dermatomyositis, and related conditions. In: Koopman W, Moreland L, editors. Arthritis and Allied Conditions, A Textbook of Rheumatology. Philadelphia: Lippincott, Williams and Wilkins; 2004. pp. 1593–1620.
-
- Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;70(6):360–74. - PubMed
-
- Rider LG, Gurley RC, Pandey JP, Garcia de la Torre I, Kalovidouris AE, O’Hanlon TP, et al. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998;41(4):710–9. - PubMed
-
- Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2002;28(4):891–916. - PubMed
-
- O’Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006;85(2):111–27. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources